维普中文期刊产品整合服务
20篇 您的检索式:作者名="STREIT JM"
    题名 作者 年代 出处 被引量
1Worldwide assessment of dalbavancinactivity and spectrum against over 6000 clinical isolates显示文摘Streit JM Fritsche TR Sader HS 2004Clin Microbiol Infect2004,48,2:1
2Antimicrobial susceptibility of gram-positive bacteria isolated from European medical centres:results of the Daptomycin Surveillance Programme ( 2002 - 2004 ) 显示文摘Sader HS Streit JM Fritsche TR 2006Clin Micmbiol Infect2006,12,:1
3Dalbavancinactivity against selected populations of antimicrobial-resistant gram-positive pathogens显示文摘Streit JM Sader HS Fritsche TR 2005Diagn Microbiol Infect Dis2005,53,4:1
4Dalbavancinactivity against selected populations of antimicrobial - resistant gram - positive pathogens 显示文摘Streit JM Sader HS Fritsche TR 2005Diagn Microbiol Infect Dis2005,53,4:1
5Antimicrobial sus ceptibility of gram-positive bacteria isolated from European medical centres: results of the Daptomycin Surveillance Pro- gramme (2002-2004)显示文摘Sader HS Streit JM Fritsche TR 2006Clin Microbiol Infect2006,12,9:1
6Antimicrobialsusceptibility of gram-positive bacteriaC2002 -2004) 显示文摘Sader HS Streit JM Fritsche TR 2006Clin Microbiol Infect2006,12,9:1
7Worldwide assessment of dalbavancinactivity and spectrum against over 6,000clinical isolates显示文摘STREIT JM FRITSCHE TR SADER HS 2004Diagn Microbiol Infect Dis2004,48,2:1
8dalbavancinactivity against selected populations of antimicrobial-resistant Grampositive pathogens显示文摘STREIT JM SADER HS FRITSCHE TR 2005Diagn Microbiol Infect Dis2005,53,4:1
9Daptomycin tested against 915 bloodstream isolates of viridans group streptococci( eight species ) and Streptococcus bovis 显示文摘Streit JM Steenbergen JN Thorne GM 2005J Antimicrob Chemother2005,55,4:1
10Validation of commercial dryform broth microdilution panels and test reproducibility for susceptibility testing of dalbavancin, a new very long-acting glycopeptide显示文摘Jones RN Streit JM Fritsche TR 2004Int J Antimicrob Agents2004,23,2:1
11Dalbavancin activity against selected populations of antimicrobial-resistant Grampositive pathogens显示文摘Streit JM Sader HS Fritsche TR 2005Diagn Microbiol Infect Dis2005,53,4:1
12Cefdinir activity against contemporary North American isolates from community-acquired urinary tract infections显示文摘Sader HS Biedenbach D J Streit JM 2005International Journal of Antimierobial Agents2005,25,1:1
13Antimicrobial susceptibility of Gram- positive bacteria isolated from European medical centres : result of the Daptomycin Surveillance Programme (2002--2004)显示文摘SADER HS STREIT JM FRITSCHE TR 2006Clin Mierobiol Infect2006,12,9:1
14Update on linezolid in vitro activity through the Zyvox Annual Appraisal of Potency and Spectrum Program,2013显示文摘Mendes RE Hogan PA Streit JM 2015Antimicrob Agents Chemother2015,59,4:1
15Zyvox Annual Appraisal of Potency and Spectrum (ZAAPS) Program: report of linezolid activity over 9 years (2004-12) 显示文摘Mendes RE Hogan PA Streit JM 2014J Antimicrob Chemother2014,69,6:1
16Antimicrobial susceptibility of gram - positive bacteria isolated from European medical centres:resuhs of the Daptomycin Surveillance Programme ( 2002 - 2004 ) 显示文摘Sader HS Streit JM Fritsche TR 2006Clin Mierobiol Infect2006,12,9:1
17Dalbavancin activity against selected populations of antimicrobial-resistant Gram-positive pathogens 显示文摘STREIT JM SADER HS FRITSCHE TR 2005Diagn Micr lnfec Dis2005,53,4:1
18Worldwide assessment of dalbavancin activity and spectrum against over 6000 clinical isolates显示文摘Streit JM Fritsche TR Sader HS 2004Diagn Microbiol Infect Dis2004,48,:1
19Dalbavancin activity against selected populations of antimicrobial-resistant Gram-positive pathogens显示文摘Streit JM Sader HS Fritsche TR 2005Diagn Microbiol Infect Dis2005,53,:1
20Antimicrobial susceptibility of gram-positive bacteria isolated from European medical centreres:results of the Daptomycin Surveillance Programme(2002-2004)显示文摘Sader HS Streit JM Fritsche TR 2006Clin Microbiol Infect2006,12,9:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费